Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

Written by Brittney Marzullo-Sojeva on 31st March 2021. Posted in Client News.

• Previous
• Next